Laura G. Hoey


  • JD, Yale Law School, 2001
  • BA, summa cum laude, University of Notre Dame, 1998; Phi Beta Kappa


  • Massachusetts, 2002
  • Illinois, 2012

Court Admissions

  • U.S. Court of Appeals for the Eighth Circuit, 2011
  • U.S. District Court for the Northern District of Illinois, 2011
  • U.S. Court of Appeals for the Seventh Circuit, 2011
  • U.S. District Court for Eastern District of Arkansas, 2007
  • U.S. District Court for the District of Massachusetts, 2002
  • U.S. Court of Appeals for the First Circuit, 2002
  • Honorable George A. O’Toole, Jr., U.S. District Court for the District of Massachusetts (2001 - 2002)
  • Women's White Collar Defense Association
  • Founder and former co-chair, Boston Chapter of the American Bar Association Young Lawyers Subcommittee for the White Collar Crime Committee
  • Illinois Super Lawyers (2017)
  • Chicago Daily Law Bulletin's “40 under 40” (2016)
  • Recognized for Federal Regulatory Law and Health Law in Leading Lawyers Network (2016)
  • Department of Health and Human Services Office of the Inspector General’s Integrity Award (2008)

Laura G. Hoey


Laura Hoey is a partner in the government enforcement practice and an Industry Group Leader for Health Care and Life Sciences at Ropes & Gray LLP in Chicago. Laura combines her trial and investigative skills as a former federal health care fraud prosecutor with extensive experience in the health care industry. Laura is known for creative and tenacious defenses and for efficient, well-managed internal investigations.

She represents clients in the pharmaceutical, medical device, diagnostic laboratory, and dental industries who are facing government investigations and Congressional inquiries. Laura conducts internal investigations in all types of government and regulatory compliance matters including:

  • potential violations of whistleblower and anti-kickback statutes and of anti-corruption and anti-bribery statutes, including the U.S. Foreign Corrupt Practices Act,
  • alleged health care fraud,
  • alleged improper marketing of pharmaceutical products and medical devices for uses for which they have not been approved by the FDA (off-label marketing), and
  • alleged violations of privacy and cybersecurity laws, including HIPAA.

As a federal prosecutor, Laura prosecuted health care fraud, kickback violations, Food, Drug and Cosmetic Act violations, document destruction and obstruction cases, and criminal HIPAA violations, as well as tax fraud and public corruption. She was first chair in five trials, winning convictions in all five.

In 2008, Laura received the Department of Health and Human Services Office of the Inspector General’s Integrity Award.

Laura is a member of the firm’s Privacy Working Group, the Co-Chair of the Firm's Women's Forum, and a Member of the Pro Bono Committee.


  • Negotiated a civil resolution for a diagnostic laboratory that was the subject of a federal investigation concerning the marketing and billing of the lab’s services, including alleged anti-kickback and false claims violations.
  • Leading internal investigations for a multinational medical device company regarding alleged Foreign Corrupt Practice Act violations in Central and South America.
  • Leading multiple internal investigations for a major pharmaceutical company into alleged Foreign Corrupt Practice Act violations in China.
  • Leading an internal investigation at a major pharmaceutical company involving allegations of clinical trial fraud.
  • Advising a private equity firm in connection with indemnification claims based on federal health care fraud investigations.  
  • Representing U.S.-based multinational medical device company in industry-wide SEC and DOJ FCPA investigations involving witnesses in 12 countries across Europe, Asia, and South America.
  • Representing a national group of physical therapy providers in a qui tam lawsuit alleging insurance reimbursement fraud.
  • Representing a dental services organization facing a Congressional inquiry.
  • Representing a health care data management client being investigated by the Office of Inspector General for the United States Postal Service.
  • Defended a pharmaceutical company in a federal health care fraud investigation alleging off-label marketing and False Claims Act violations.
  • Represented a recipient of a Department of Homeland Security subpoena.



  • Speaker, “Mini Summit III: Enforcement Trends, Risk Assessments and Best Practices for Patient Assistance and Reimbursement Support,” 18th Annual Pharmaceutical and Medical Device Compliance Congress (November 6-8, 2017) 
  • Speaker, “The Rise of Health Care Related Legislation and Prosecution on a Global Scale,” ABA’s sixth annual London White Collar Crime Institute (October 9, 2017)
  • Speaker, “Health Care Fraud Enforcement Summit,” Legal 500 (October 3, 2017)  
  • Speaker, “Conducting the Internal Investigation,” PLI’s Internal Investigations 2016 (June 7, 2016)
  • Presenter, “Pharmaceutical Compliance Forum Spring Meeting,” Boston, MA (April 13-14, 2016)
  • Presenter, “The Yates Memorandum and Individual Liability: Implications for Compliance Officers, Board Members and Senior Leadership,” Ropes & Gray Roundtable (April 13, 2016)
  • Panelist, “Healthcare Fraud: Education to Protect Yourself, Your Community and Your Company,” Healthcare Businesswomen’s Association (March 16, 2016)
  • Moderator, “U.S. Attorney’s Office Roundtable: The Enforcers Speak,” American Conference Institute’s 16th Annual Forum on Fraud and Abuse in the Sales and Marketing of Medical Devices: Fortifying Compliance Protocols to Prepare for Changing Enforcement Priorities, Boston, MA (March 9, 2016)
  • Moderator, “Healthcare Fraud; How it Impacts You and What You Can Do,” Healthcare Businesswomen’s Association (March 6, 2016)
  • Moderator, “Emerging Enforcement Trends in Healthcare,” 30th Annual National Institute on White Collar Crime (March 3, 2016)
  • Presenter, “Be Vigilant! The Current State of Health Care Data Privacy Enforcement and What You Can Do to Prepare,” Association of Corporate Counsel, Chicago Chapter (February 24, 2016)
  • Speaker, “Conducting the Investigation,” PLI's Internal Investigations (June 9, 2015)
  • Panelist, Healthcare Fraud & Abuse Panel, 2015 ABA White Collar Crime Conference, New Orleans (March 2015)
  • Lecturer, “Government Investigations; Self disclosure; Corporate Integrity Agreements/Deferred Prosecution Agreements,” Health Care Fraud and Abuse: Contracting and Compliance, American University Washington College of Law, Washington, DC (November 18, 2014)
  • Moderator, AdvaMed 2014 MedTech Conference, Chicago (October 6-8 2014)
  • Moderator, Chambers & Partners, General Counsel Seminar (September 30, 2014)
  • Presenter, Practising Law Institute Internal Investigations Conference, Chicago (June 10, 2014)
  • Moderator, 7th Annual Conference – White Collar Crime / Corporate Governance, Westin River North, Chicago (April 17, 2014)
  • Moderator, ASECA Securities Enforcement and Regulation Conference, The Metropolitan Club, Chicago (April 13, 2014)
  • Presenter, Yale Law Women – “Day in the Life” Series, New Haven, CT (February 27, 2014)
  • Speaker, “Commencing the Investigation: Considerations at the Outset,” PLI's Internal Investigations, Chicago (June 11, 2013)
  • Panelist, “Under the Government Microscope: Health Care Fraud Issues under FCPA,” Law Bulletin’s 6th Annual White Collar Conference (April 16, 2013)
  • Co-Presenter, “HIPAA Omnibus Rule: Considerations and Updates Related to Recent Government Enforcement Activity, Data Breach Litigation and Liability Risk Management,” Ropes & Gray Webinar (March 12, 2013)
  • Co-Panelist, “Perspective of a Qui Tam Plaintiff’s Lawyer,” Ropes & Gray False Claims Act Roundtable, New York, NY (February 12, 2013)
  • Presenter, “Regulatory and Enforcement Update,” ACS - Financial Accounting & Reporting Update Conference, Chicago, IL (November 15-16, 2012)
  • Presenter, “UK’s Anti-Bribery Act: Increasing Global Awareness, Enforcement and Investigation,” 3rd Annual Device and Diagnostic Ethics and Compliance Conference, Chicago, IL (October 15-16, 2012)
  • Presenter, “Arkansas Medicaid Fraud, Case Study: U.S. of America v. Kelly Dean Shrum, D.O.,” National Association of Medicaid Fraud Control Units, 2012 Annual Training Program, New York, NY (October 2, 2012)
  • Presenter, “New Challenges Under Dodd-Frank,” ACS - Revenue Recognition Conference (September 13, 2012)
  • Moderator, “Health Care Fraud Update: 2012,” ABA 2012 Annual Meeting, Criminal Justice Section (August 4, 2012)
  • Speaker, “SEC Enforcement Discussion,” Revenue Recognition Accounting Update Conference (June 21, 2012)
  • Moderator, “Health Care Fraud,” White Collar Crime + Corporate Governance Conference (April 18, 2012)
  • Co-Presenter, “When the Government Comes Calling: Calibrating Your Response to the Government’s Method of Inquiry,” Healthcare Financial Management Association, Illinois First Chapter (January 2012)
  • Co-Presenter with Colleen Conry, “Prosecuting and Defending Individuals in White Collar Criminal Cases,” Chicago Bar Association, Corporate Law Department’s Committee (June 16, 2011)
  • Panelist, "Internal Investigations 2011: Investigations in the Aftermath of Dodd-Frank," Practising Law Institute (June 14, 2011)
  • Presenter, “Working Collaboratively to Fight Fraud in DME Cases,” Medicaid Integrity Institute Seminar Emerging Trends in Home Health and Durable Medical Equipment Symposium, Columbia, SC (September 21, 2010)
  • Presenter, “Health Care Fraud and Parallel Proceedings,” National Advocacy Center, Department of Justice training course Survey of White Collar Crime, Columbia, SC (July 14, 2010 and May 12, 2009)
  • Presenter, “Kickbacks in the Medical Supply Arena,” Health and Human Services Office of Inspector General Regional Training, New Orleans, LA (June 17, 2009)
  • Presenter, “Sale and Marketing of Medical Devices, Enforcement Panel,” American Conference Institute Medical Device Conference, Chicago, IL (November 19, 2008)